Myriad Genetics Included in Forbes America’s Best Employers 2025 List
Myriad Genetics (NASDAQ: MYGN) has been recognized on the Forbes America's Best Employers 2025 list, a distinction determined through collaboration with Statista. The selection process involved an independent survey of over 217,000 U.S. employees from companies with 1,000+ employees, considering more than 6.5 million employer evaluations.
The company's strong workplace culture is evidenced by its employee satisfaction rates, with 84% of employees rating it as a Great Place To Work — surpassing the U.S. company average by 27 percentage points. The final rankings were based on both personal evaluations from employees and public feedback from industry professionals and employee connections, with greater emphasis placed on direct employee assessments.
Chief People Officer Shereen Solaiman highlighted the company's commitment to innovation and employee empowerment in advancing health and wellbeing solutions.
Myriad Genetics (NASDAQ: MYGN) è stata riconosciuta nella lista dei Forbes America's Best Employers 2025, un riconoscimento ottenuto grazie alla collaborazione con Statista. Il processo di selezione ha coinvolto un'indagine indipendente su oltre 217.000 dipendenti statunitensi di aziende con più di 1.000 dipendenti, considerando oltre 6,5 milioni di valutazioni dei datori di lavoro.
La forte cultura aziendale è dimostrata dai tassi di soddisfazione dei dipendenti, con l'84% dei dipendenti che la valuta come un ottimo posto di lavoro — superando la media aziendale statunitense di 27 punti percentuali. Le classifiche finali si basavano sia sulle valutazioni personali dei dipendenti sia sul feedback pubblico di professionisti del settore e contatti con i dipendenti, con maggiore enfasi sulle valutazioni dirette dei dipendenti.
Il Chief People Officer Shereen Solaiman ha sottolineato l'impegno dell'azienda per l'innovazione e l'empowerment dei dipendenti nel promuovere soluzioni per la salute e il benessere.
Myriad Genetics (NASDAQ: MYGN) ha sido reconocida en la lista de Forbes America's Best Employers 2025, una distinción determinada en colaboración con Statista. El proceso de selección incluyó una encuesta independiente a más de 217,000 empleados en EE. UU. de empresas con más de 1,000 empleados, considerando más de 6.5 millones de evaluaciones de empleadores.
La sólida cultura laboral de la empresa se evidencia en sus tasas de satisfacción de los empleados, con el 84% de los empleados calificándola como un gran lugar para trabajar — superando en 27 puntos porcentuales el promedio de las empresas en EE. UU. Los rankings finales se basaron tanto en evaluaciones personales de los empleados como en comentarios públicos de profesionales de la industria y conexiones de empleados, con mayor énfasis en las evaluaciones directas de los empleados.
La directora de personas, Shereen Solaiman, destacó el compromiso de la empresa con la innovación y el empoderamiento de los empleados en el avance de soluciones de salud y bienestar.
Myriad Genetics (NASDAQ: MYGN)는 포브스 아메리카 최고의 고용주 2025 목록에 선정되었습니다. 이 명성은 Statista와의 협력을 통해 결정되었습니다. 선정 과정은 1,000명 이상의 직원을 둔 기업의 미국 내 217,000명 이상의 직원에 대한 독립적인 설문조사를 포함하여, 650만 건 이상의 고용주 평가를 고려했습니다.
회사의 강력한 직장 문화는 직원 만족도에서 입증되었으며, 직원 중 84%가 이를 훌륭한 직장으로 평가하여 미국 기업 평균보다 27포인트를 초과합니다. 최종 순위는 직원들의 개인 평가와 업계 전문가 및 직원 네트워크의 공개 피드백을 바탕으로 하였으며, 직접적인 직원 평가에 더 큰 비중이 두어졌습니다.
최고 인사 책임자 Shereen Solaiman은 건강 및 웰빙 솔루션을 발전시키기 위한 회사의 혁신과 직원 권한 부여에 대한 헌신을 강조했습니다.
Myriad Genetics (NASDAQ: MYGN) a été reconnue dans la liste des Forbes America's Best Employers 2025, une distinction déterminée en collaboration avec Statista. Le processus de sélection a impliqué une enquête indépendante auprès de plus de 217 000 employés américains d'entreprises comptant plus de 1 000 employés, prenant en compte plus de 6,5 millions d'évaluations des employeurs.
La forte culture d'entreprise est attestée par les taux de satisfaction des employés, avec 84 % des employés la qualifiant de formidable lieu de travail — dépassant de 27 points de pourcentage la moyenne des entreprises américaines. Les classements finaux étaient basés à la fois sur des évaluations personnelles des employés et sur des retours publics de professionnels du secteur et de connexions avec les employés, en mettant davantage l'accent sur les évaluations directes des employés.
La directrice des ressources humaines, Shereen Solaiman, a souligné l'engagement de l'entreprise envers l'innovation et l'autonomisation des employés pour faire progresser les solutions de santé et de bien-être.
Myriad Genetics (NASDAQ: MYGN) wurde in die Liste der Forbes America's Best Employers 2025 aufgenommen, eine Auszeichnung, die in Zusammenarbeit mit Statista ermittelt wurde. Der Auswahlprozess umfasste eine unabhängige Umfrage unter über 217.000 US-Mitarbeitern von Unternehmen mit mehr als 1.000 Mitarbeitern und berücksichtigte mehr als 6,5 Millionen Arbeitgeberbewertungen.
Die starke Unternehmenskultur des Unternehmens zeigt sich in den Mitarbeiterzufriedenheitsraten, wobei 84% der Mitarbeiter es als einen großartigen Arbeitsplatz bewerten — was 27 Prozentpunkte über dem US-Durchschnitt liegt. Die endgültigen Rankings basierten sowohl auf persönlichen Bewertungen der Mitarbeiter als auch auf öffentlichen Rückmeldungen von Branchenexperten und Mitarbeiterverbindungen, wobei der Schwerpunkt auf den direkten Mitarbeiterbewertungen lag.
Chief People Officer Shereen Solaiman hob das Engagement des Unternehmens für Innovation und die Befähigung der Mitarbeiter zur Förderung von Gesundheits- und Wellnesslösungen hervor.
- None.
- None.
SALT LAKE CITY, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, has been named on the Forbes list of America’s Best Employers 2025. This prestigious recognition is presented in collaboration with Statista, the world-leading statistics portal and industry ranking provider.
“Working at Myriad Genetics means being part of a dynamic team dedicated to empowering every individual by revealing the answers inside each of us. Our teammates are driven to innovate solutions that change lives,” said Shereen Solaiman, chief people officer, Myriad Genetics. “I want to commend our teammates, who are dedicated to advancing health and wellbeing for all.”
Being included on the Forbes list is the latest accolade for the company. Last year,
Forbes and Statista selected America’s Best Employers 2025 through an independent survey from a vast sample of more than 217,000 U.S. employees working for companies employing at least 1,000 people within the U.S. More than 6.5 million employer evaluations were considered. The final score is based on two types of evaluations: personal (those given by employees themselves) and public (those given by friends and family members of employees, or members of the public who work in the same industry), with a much higher weighting for personal evaluations.
For more information about careers at Myriad, please visit: https://myriad.com/careers/.
About Statista
Statista publishes hundreds of worldwide industry rankings and company listings with high-profile media partners. This research and analysis service is based on the success of statista.com, the leading data and business intelligence portal that provides statistics, business-relevant data, and various market and consumer studies and surveys.
About Myriad Genetics
Myriad Genetics is a leading genetic and genomic tumor testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Kate Schraml
(224) 875-4493
PR@myriad.com
FAQ
How did Myriad Genetics (MYGN) rank in Forbes America's Best Employers 2025?
What percentage of Myriad Genetics employees rated it as a Great Place to Work in 2024?
How many employee evaluations were considered for Forbes' 2025 Best Employers list?
What criteria did Forbes use to select companies for their 2025 Best Employers list?
